-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $100

Benzinga·07/10/2026 10:38:09
Listen to the news
Citigroup analyst Eric Joseph maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $115 to $100.